What Is Nonacid Reflux Disease?
Proton pump inhibitors (PPIs) are the gold standard treatment for gastroesophageal reflux disease. In clinical practice, failure of PPIs occurs frequently, and may affect up to 30% of patients in a typical gastroenterology practice. Multichannel impedance monitoring combined with pH monitoring helps...
Saved in:
| Main Author: | Martin A Storr |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2011-01-01
|
| Series: | Canadian Journal of Gastroenterology |
| Online Access: | http://dx.doi.org/10.1155/2011/626752 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Predictive factors for neuromodulator response in patients with nonacid gastroesophageal reflux-induced chronic cough: a retrospective data analysis
by: Obama Oyana Marcelina Asangono, et al.
Published: (2025-05-01) -
Mean Nocturnal Baseline Impedance (MNBI) Provides Evidence for Standardized Management Algorithms of Nonacid Gastroesophageal Reflux-Induced Chronic Cough
by: Yiqing Zhu, et al.
Published: (2023-01-01) -
Sjögren’s Disease and Gastroesophageal Reflux Disease: What Is Their Evidence-Based Link?
by: Diana Mieliauskaitė, et al.
Published: (2024-11-01) -
Gastroesophageal Reflux Symptoms not Responding to Proton Pump Inhibitor: GERD, NERD, NARD, Esophageal Hypersensitivity or Dyspepsia?
by: Mohammad Bashashati, et al.
Published: (2014-01-01) -
Heartburn, gastro-oesophageal reflux disease and non-erosive reflux disease
by: Haley Smith
Published: (2016-11-01)